Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction
Status:
Recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
Main objective: To evaluate the efficacy, safety and clinical dose exploration of Qishen Yiqi
dripping pills in the treatment of chronic heart failure with preserved ejection fraction.
Exploratory research objective: To explore the changes of endogenous substances in vivo
before and after drug administration, to interpret the mechanism of drug action through
metabolomics and systems biology methods, and to find potential clinical biomarkers for
exploratory subgroup analysis of clinical trials.